Editas Medicine Inc (EDIT)

R&D Expense Growth

612.82%

Quarterly · Period ending:

EDIT logo

EDIT R&D Expense Growth

Latest reported612.82%
EDIT Quarterly R&D Growth (QoQ) (0.00% → 612.82%)
High-resolution chart · PNG

EDIT r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Editas Medicine Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
612.8223%
-89.6694%
38.579%
22.2112%
-39.1532%
-45.2943%
2.0403%
-9.7575%
11.423%
-30.4186%
1,176.0495%
-82.0813%
-21.2279%
-27.2972%
25.8239%
-5.3437%
14.9647%
1.1264%
28.3205%
-13.2966%
-19.515%
-31.8142%
81.3421%
21.0983%
-18.9847%
-0.6295%
53.242%
-3.6622%
48.7502%
-17.4681%
10.0441%
-46.6868%
53.6056%
-19.3915%
29.5548%
17.7734%
-8.9533%
-29.1187%
147.7382%
3.8543%
17.4285%
52.4545%
51.3247%
-47.1299%
285.6992%
-21.1691%
90.9888%
76.1236%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.